Milestone Pharmaceuticals Financial Overview
Milestone Pharmaceuticals's market cap is currently $251.25M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Milestone Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
